These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 1763895

  • 21. [Carnitine deficiency: a treatable cardiomyopathy].
    Hirata K, Yoshioka F, Eto Y, Suzuki K, Yokochi K, Kato H, Ohta K, Terasawa M.
    J Cardiogr; 1986 Mar; 16(1):217-25. PubMed ID: 3782884
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy.
    Matsuishi T, Hirata K, Terasawa K, Kato H, Yoshino M, Ohtaki E, Hirose F, Nonaka I, Sugiyama N, Ohta K.
    Neuropediatrics; 1985 Feb; 16(1):6-12. PubMed ID: 3974805
    [Abstract] [Full Text] [Related]

  • 24. The role of L-carnitine in pediatric cardiomyopathy.
    Winter S, Jue K, Prochazka J, Francis P, Hamilton W, Linn L, Helton E.
    J Child Neurol; 1995 Nov; 10 Suppl 2():S45-51. PubMed ID: 8576569
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Diagnosis of mitochondrial fatty acid oxidation defects.
    Duran M, Bruinvis L, Ketting D, Dorland L.
    Padiatr Padol; 1993 Nov; 28(1):19-25. PubMed ID: 8446424
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts.
    Pande SV, Brivet M, Slama A, Demaugre F, Aufrant C, Saudubray JM.
    J Clin Invest; 1993 Mar; 91(3):1247-52. PubMed ID: 8450053
    [Abstract] [Full Text] [Related]

  • 29. Implications of impaired ketogenesis in fatty acid oxidation disorders.
    Olpin SE.
    Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):293-308. PubMed ID: 14769488
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
    Vockley J, Marsden D, McCracken E, DeWard S, Barone A, Hsu K, Kakkis E.
    Mol Genet Metab; 2015 Mar; 116(1-2):53-60. PubMed ID: 26116311
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Carnitine deficiency in inborn errors of metabolism].
    Sela BA, Lerman-Sagie T, Berkovitz M.
    Harefuah; 1997 Nov 16; 133(10):419-23, 504. PubMed ID: 9418309
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Systemic carnitine deficiency.
    McGarry JD, Foster DW.
    N Engl J Med; 1980 Dec 11; 303(24):1413-5. PubMed ID: 7432389
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Bezafibrate for an inborn mitochondrial beta-oxidation defect.
    Bonnefont JP, Bastin J, Behin A, Djouadi F.
    N Engl J Med; 2009 Feb 19; 360(8):838-40. PubMed ID: 19228633
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.